DoD Toxic Exposures Clinical Trial Partnership Award
ID: 359256Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359256
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is inviting applications for the FY25 Toxic Exposures Research Program (TERP) Clinical Trial Partnership Award (CTPA), aimed at supporting collaborative clinical trials focused on health issues related to military-related toxic exposures. The initiative seeks to rapidly implement studies that address the prevention, treatment, and management of diseases or symptoms resulting from such exposures, with an estimated total program funding of $4.2 million available for this purpose. Eligible applicants include a wide range of nonprofit and for-profit organizations, with a requirement for partnerships involving multiple Principal Investigators (PIs) to enhance collaboration and research efficacy. Interested parties should note that the application process involves a two-step submission of a pre-application and full application, with a closing date set for October 16, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942525TERPCTPA_GG.pdf
    The Department of Defense (DOD) is seeking applications for the FY25 Toxic Exposures Research Program (TERP) Clinical Trial Partnership Award (CTPA) to support collaborative clinical trials addressing health issues related to military-related toxic exposures. Approximately $4.2 million is earmarked for this initiative, with a focus on rapid implementation of studies aimed at prevention, treatment, and management of diseases or symptoms tied to such exposures. Eligible applicants include various nonprofit and for-profit organizations, with a requirement for partnerships involving multiple Principal Investigators (PIs). The application process involves a two-step submission of a pre-application and full application through designated platforms. Key components of the proposals must involve clear hypotheses, study design, and detailed plans addressing military health needs, including identifying and enrolling relevant military and Veteran populations. The projects should focus on long-term health impacts, diagnosis, and therapeutics related to toxic exposure, adhering to specific funding limitations and ethical guidelines. Moreover, collaboration with DOD and Veterans Affairs researchers is encouraged. The initiative reflects the DOD's commitment to advancing medical research that improves the quality of life for Service Members and their families affected by toxic exposures.
    Similar Opportunities
    Request for Information Trusted Partner Program
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is seeking feedback through a Request for Information (RFI) for its Trusted Partner Program (TPP), aimed at establishing a network of external academic partners capable of conducting basic scientific research. This initiative is designed to create multiple five-year Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts to facilitate agile research and advanced technology development across various technical fields. The program is crucial for enhancing the Army's access to expert talent and expediting science-driven capabilities for national security. Interested institutions must demonstrate robust security clearances and research capabilities, with responses to the RFI due by December 31, 2025. For further inquiries, potential respondents can contact Meaghan Pimsler at DEVCOMARLTPP@army.mil.
    Military and Civilian Partnership for Trauma Readiness Grant Program/Mission Zero
    Admin for Strategic Preparedness and Response
    The Administration for Strategic Preparedness and Response is offering the Military and Civilian Partnership for Trauma Readiness Grant Program, also known as the Mission Zero Act, to support high-acuity trauma centers in enhancing military-civilian partnerships for improved trauma care. This grant program aims to award up to 30 eligible trauma centers, enabling military trauma teams to provide full-time trauma and acute care services, thereby strengthening the nation's response to public health and medical emergencies. With an estimated total program funding of $4 million and an award ceiling of $4 million per grant, interested applicants, including nonprofits without 501(c)(3) status and hospitals, should note that the application period is expected to open on January 15, 2025, with a closing date of April 14, 2025. For further inquiries, applicants can contact Leslie Beck at 301-346-4857 or via email at leslie.beck@hhs.gov.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has announced a Broad Agency Announcement (BAA) for Extramural Biomedical and Human Performance Research and Development. This opportunity invites unrestricted applicants to submit proposals aimed at advancing biomedical research and development, with a focus on enhancing human performance. The program is critical for fostering innovation in science and technology, particularly in areas that support the Department of Defense's mission. The estimated total program funding is $10 million, with individual awards ranging from $750,000 to $50 million, and proposals are due by July 31, 2028. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    Tactical Behaviors for Autonomous Maneuver
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is offering a funding opportunity through the Tactical Behaviors for Autonomous Maneuver Collaborative Research Program (TBAM-CRP) aimed at enhancing the capabilities of robotic and autonomous systems (RAS) for military operations in complex environments. This program seeks proposals that develop coordinated and adaptive behaviors for small groups of autonomous agents, focusing on innovative maneuver tactics and strategies to operate effectively in multi-domain operations against peer adversaries. The TBAM-CRP is critical for advancing military capabilities, leveraging new technologies in robotics and autonomous systems to improve situational awareness and operational effectiveness on the battlefield. Interested applicants, including institutions of higher education and for-profit organizations, are invited to submit proposals by April 24, 2024, with funding amounts ranging from $100,000 to $2.3 million available per award. For further inquiries, applicants can contact Christopher D. Justice at usarmy.adelphi.devcom-arl.mbx.tbam-crp-questions@army.mil.
    Staff Research Program
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is offering a funding opportunity for the Staff Research Program, aimed at engaging scientific staff in collaborative research with higher education institutions. This program seeks to enhance the professional competence of Army Research Office (ARO) scientists through hands-on, fundamental research in various scientific fields, including engineering, physical sciences, and life sciences, with a focus on advancing knowledge relevant to Army missions. Eligible applicants include institutions recognized for their scientific research capabilities, and the funding will be provided through cooperative agreements with award amounts ranging from $200,000 to $10 million. Proposals must be submitted via Grants.gov by June 2, 2030, and interested parties can contact Mr. William Creech at William.a.creech3.civ@army.mil for further information.
    CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms," aimed at supporting research into the mechanisms of chemical toxicity affecting the lungs and eyes. This initiative seeks to fund projects that explore the health impacts of chemical threat agents, with a focus on identifying molecular and genetic targets for therapeutic countermeasures, utilizing various research methodologies such as animal models and computational modeling. A total of approximately $3 million is available to support up to five grants, with each project eligible for a maximum budget of $300,000 per year over a three-year period. Interested applicants should note that the application period opens on August 24, 2024, with a final submission deadline of September 24, 2026, and can direct inquiries to grantsinfo@nih.gov for further information.
    NFRP Outreach and Invitation for Response
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is forecasting an opportunity for a Research-based Other Transactions Agreement (rOTA) under the Neurofibromatosis Research Program (NFRP). This initiative aims to accelerate the clinical translation of basic research related to neurofibromatosis (NF) by conducting collaborative Phase I and II clinical trials focused on promising therapeutic agents for NF1, NF2, and schwannomatosis. Historically, this requirement has been addressed through assistance agreements, and the government is now seeking feedback on this proposed approach, emphasizing the need for cost-sharing arrangements and access to patient populations. Interested parties can direct inquiries to Jason D. Kuhns at jason.d.kuhns.civ@mail.mil, with the opportunity being part of the FY21 portfolio and requiring a demonstrated history of collaborative research among participants.
    Department of Defense HIV/AIDS Prevention Program
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering a federal grant opportunity titled the Department of Defense HIV/AIDS Prevention Program (DHAPP). This program aims to save lives and prevent HIV infections by supporting the development of interventions and programs within military health systems, particularly in foreign countries, to achieve HIV/AIDS epidemic control. The DHAPP focuses on enhancing military capacity for ownership and behavioral change, aligning with national strategies, and ensuring sustainable HIV prevention and treatment services. Interested applicants can reach out to Ebony Simmons at ebony.s.simmons.civ@health.mil or by phone at 301-619-2105 for further information. The application deadline is September 18, 2027, with an expected seven awards to be made under this cooperative agreement, which does not require cost sharing or matching.
    Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity for Cooperative Research Agreements related to the World Trade Center (WTC) Health Program, aimed at addressing health conditions stemming from the September 11, 2001, terrorist attacks. This initiative seeks scientifically rigorous research proposals that focus on improving diagnosis and treatment, expanding knowledge about health effects, and enhancing response strategies for future disasters, particularly for WTC responders and survivors. With an estimated total program funding of $41.25 million and an award ceiling of $550,000, the CDC anticipates making approximately 25 awards. Interested applicants can reach out to Dr. James Yiin at JYiin@cdc.gov or call 513-841-4271 for further information, with applications due by October 28, 2025, and awards expected to be announced by June 26, 2026.
    Notice of Intent to Publish a Funding Opportunity Announcement for CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for the Countermeasures Against Chemical Threats (CounterACT) initiative, focusing on the early-stage development of therapeutics to address health impacts from toxic chemical exposure. This funding opportunity aims to foster collaborations and innovative projects that can effectively mitigate adverse health effects, with an emphasis on the UG3/UH3 activity code for phased development. The NOFO is anticipated to be released in early 2025, with applications due by October 2025, and awards expected to be made by June 2026, marking a significant investment in public health safety. Interested applicants should prepare to align their proposals with the outlined objectives and timelines.